Summary
- Current Price
- As of today, RVMD price is $203.71, up +0.85% on
- Current Price All-Time High
- RVMD price is currently -2.42% below its historical high of $208.76 set on
- Market Cap
- RVMD current market cap is $44B, up +548.56% over the past 365 days
- Revenue
- RVMD current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RVMD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Revolution Medicines, Inc. |
| Ticker | NASDAQ: RVMD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | revmed.com |
| Employees | 616 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $203.71 | |
| Price, 1D Change | +0.85% | |
| Market Cap | $44B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.17 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$5.95 | |
| EPS, 1Y Change | -66.32% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$5.95 | |
| EPS Estimate | -$9.57 | N/A |
| EPS Est. Change | -60.80% | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | $133.42M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $203.71 | |
| Price Target | $225.00 | - |
| Price Tgt. Change | +10.45% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.43 | -$3.58 | -4.21% | |
| -$5.53 | -$5.95 | -7.63% | |
| -$9.57 | N/A | -60.80% | |
| -$6.83 | N/A | -14.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $346.15K | $0.00 | -100.00% | |
| $3.89M | $0.00 | -100.00% | |
| $133.42M | N/A | - | |
| $975.51M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +465.55% | |
| Price, 3Y | +579.03% | |
| Market Cap, 1Y | +548.56% | |
| Market Cap, 3Y | +1,233.52% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | -100.00% | |
| EPS, 1Y | -66.32% | |
| EPS, 3Y | -92.90% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $203.71 | |
| SMA 200 | $122.07 | |
| SMA 50 | $179.68 | |
| EMA 200 | $130.80 | |
| EMA 50 | $180.39 | |
| MACD | $6.86 | |
| Beta | 1.17 | |
| ATR | $7.11 | |
| 14-Day RSI | 63.34 | |
| 10-Day Volatility | 43.69% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$5.95 | |
| Gross Profit | -$16.56M | |
| Gross Margin | - | |
| Operating Income | -$1.18B | |
| Operating Margin | - | |
| Net Income | -$1.13B | |
| Net Margin | - | |
| EBITDA | -$1.17B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.26 | |
| 7.14 | ||
| 7.14 | ||
| - | ||
| - | ||
| 31.31 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 16.75 | ||
| -25.43 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.63B | |
| $2.03B | ||
| $2.41B | ||
| $2.08B | ||
| $777.09M | ||
| $290.42M | ||
| Total Debt | $427.15M | |
| $16.47M | ||
| $64.62M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.13B | ||
| $1.17B | ||
| $16.56M | ||
| $0.00 | ||
| $16.56M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$897.74M | ||
| $118.06M | ||
| $621.52M | ||
| Capex | $15.99M | |
| -$913.73M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| Wedbush | → | |
| RBC Capital | → | |
| Needham | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| Wedbush | → | |
| Needham | → | |
| Guggenheim | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RVMD
FAQ
- What is the ticker symbol for Revolution Medicines, Inc.?
- The ticker symbol for Revolution Medicines, Inc. is NASDAQ:RVMD
- Does Revolution Medicines, Inc. pay dividends?
- No, Revolution Medicines, Inc. does not pay dividends
- What sector is Revolution Medicines, Inc. in?
- Revolution Medicines, Inc. is in the Healthcare sector
- What industry is Revolution Medicines, Inc. in?
- Revolution Medicines, Inc. is in the Biotechnology industry
- What country is Revolution Medicines, Inc. based in?
- Revolution Medicines, Inc. is headquartered in United States
- When did Revolution Medicines, Inc. go public?
- Revolution Medicines, Inc. initial public offering (IPO) was on February 13, 2020
- Is Revolution Medicines, Inc. in the S&P 500?
- No, Revolution Medicines, Inc. is not included in the S&P 500 index
- Is Revolution Medicines, Inc. in the NASDAQ 100?
- No, Revolution Medicines, Inc. is not included in the NASDAQ 100 index
- Is Revolution Medicines, Inc. in the Dow Jones?
- No, Revolution Medicines, Inc. is not included in the Dow Jones index
- When was Revolution Medicines, Inc. last earnings report?
- Revolution Medicines, Inc.'s most recent earnings report was on August 5, 2026
- When does Revolution Medicines, Inc. report earnings?
- The next expected earnings date for Revolution Medicines, Inc. is November 4, 2026
Data Sources & References
- RVMD Official Website www.revmed.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1628171/000119312526071563/0001193125-26-071563-index.htm
- RVMD Profile on Yahoo Finance finance.yahoo.com/quote/RVMD
- RVMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rvmd